首页> 外国专利> PHARMACEUTICAL COMPOSITIONS OF 7 (6 (2 HYDROXYPROPAN 2 YL)PYRIDIN 3 YL) 1 ((TRANS) 4 METHOXYCYCLOHEXYL) 3 4 DIHYDROPYRAZINO 2 3 IB/IPYRAZIN 2(1IH/I) ONE A SOLID FORM THEREOF AND METHODS OF THEIR USE

PHARMACEUTICAL COMPOSITIONS OF 7 (6 (2 HYDROXYPROPAN 2 YL)PYRIDIN 3 YL) 1 ((TRANS) 4 METHOXYCYCLOHEXYL) 3 4 DIHYDROPYRAZINO 2 3 IB/IPYRAZIN 2(1IH/I) ONE A SOLID FORM THEREOF AND METHODS OF THEIR USE

机译：7（6（2羟丙烷2 YL）吡啶3 YL）1（（TRANS）4甲氧环己基）3 4双羟基吡嗪并[2 3 B ]吡嗪2（1 H ）一种固体形式及其使用方法

展开▼

页面导航

摘要

著录项

相似文献

摘要

ptran)SbHProvided herein are compositions of 7 (6 (2 hydroxypropan 2 yl)pyridin 3 yl) l (( 4 methoxycyclohexyl) 3 4 dihydropyrazino[2 3 ]pyrazin 2( 1) one solid forms isotopologues and metabolites thereof and methods of their use for the treatment of a disease disorder or condition./p 展开▼

机译：本文提供的是7（6（2（羟基脯氨酸2羟基）吡啶3 yl）l（（4甲氧基环己基）3 4 dihydropyrazino [2 3] pyrazin 2（1））的一种固体形式的同位素异构体及其代谢产物和方法用于治疗疾病或病症的方法。展开▼

著录项

公开/公告号IN2014CN04037A

专利类型

公开/公告日2015-10-23

原文格式PDF

申请/专利权人 SIGNAL PHARM LLC;
展开▼

申请/专利号IN4037/CHENP/2014

发明设计人 ASSAF MAHMOUD S;CONNOLLY TERRENCE JOSEPH;JAMES ANGELA JOUBERT;KLOPFER KEVIN JOSEPH;LEONG WILLIAM WEI HWA;MENON ANIL;MIKLOS AMANDA NICOLE;
展开▼

申请日2014-05-29

分类号A61K9/28;A61K9;A61K9/20;

国家 IN

入库时间 2022-08-21 15:14:47

相似文献

专利

外文文献

中文文献

1. 7‑(6‑(2‑羟基丙烷‑2‑基)吡啶‑3‑基)‑1‑((反式)‑4‑甲氧基环己基)‑3,4‑二氢吡嗪并2,3‑B吡嗪‑2(1H)‑酮、其固体形式的药物组合物及其使用方法 [P] . 中国专利： CN104093398B . 2017.03.15

2. 7-(6-(2-羟基丙烷-2-基)吡啶-3-基)-1-((反式)-4-甲氧基环己基)-3,4-二氢吡嗪并2,3-B吡嗪-2(1H)-酮、其固体形式的药物组合物及其使用方法 [P] . 中国专利： CN104093398A . 2014-10-08

3. PHARMACEUTICAL COMPOSITIONS OF 7 (6 (2 HYDROXYPROPAN 2 YL)PYRIDIN 3 YL) 1 ((TRANS) 4 METHOXYCYCLOHEXYL) 3 4 DIHYDROPYRAZINO 2 3 IB/IPYRAZIN 2(1IH/I) ONE A SOLID FORM THEREOF AND METHODS OF THEIR USE [P] . IN4037CHN2014A . 2015-10-23

机译： 7（6（2羟丙烷2 YL）吡啶3 YL）1（（TRANS）4甲氧环己基）3 4双羟基吡嗪并[2 3 B ]吡嗪2（1 H ）一种固体形式及其使用方法

4. PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO 2,3-iB/iPYRAZIN-2(1iH/i)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE [P] . SG11201402766UA . 2014-06-27

机译： 7-（6-（2-（羟基丙烷-2-基）吡啶基-3-基）-1-（（反式）-4-甲氧基环己基）-3,4-二羟基吡嗪并[2,3- B]的药物成分] PYRAZIN-2（1 H ）-one，一种固体形式，其使用方法

5. PHARMACEUTICAL COMPOSITIONS OF 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN -3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-3,4-DIHYDROPYRAZINO 2,3-B/iPYRAZIN-2(1H/i)-ONE, A SOLID FORM THEREOF AND METHODS OF THEIR USE. [P] . MX363034B . 2019-03-06

机译： 7-（6-（2-（羟基丙烷-2-基）吡啶基-3-基）-1-（（反式）-4-甲氧基环己基）-3,4-二氢吡嗪[2,3-B ] PYRAZIN-2（1H ）-one，其固体形式及其使用方法。

1. Formation of 2,4,5-triaryl-4,5-dihydro-1H-imidazoles, (1), from aryl aldehydes. Crystal structures of cis-(1: aryl = pyridin-2-yl), {trans-[(1: aryl = pyridin-2-yl)H]+[OAc]-·3H2O}, {cis-[1: aryl = thien-2-yl]·0.5H2O} and trans-(1: aryl = thien-2-yl [J] . Christiane Fernandes, Adolfo Horn Jr., R. Alan Howie, Journal of Molecular Structure . 2007,第1a3期

2. Improving the Pharmacokinetic and CYP Inhibition Profiles of Azaxanthene-Based Glucocorticoid Receptor Modulators-Identification of (S)-5-(2-(9-Fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341) [J] . Yang Michael G., Dhar T. G. Murali, Xiao Zili, Journal of Medicinal Chemistry . 2015,第10期

3. Poly[[[μ-trans-1,2-bis-(pyridin-4-yl)ethene-κ2N:N′]-μ-iodido-copper(I)]–trans-1,2-bis-(pyridin-4-yl)ethene (1/0.25)] [J] . Hoffman J.L., Akhigbe J.E., Reinheimer E.W., IUCrData . 2020,第7期

4. Formation of a Dinuclear Copper(II) Complex through the Cleavage of C-N Bond of 1-Benzoyl-3-(pyridin-2-yl)-1Hpyrazole [C] . Rosidah Shardin, Law Kung Pui, Bohari M. Yamin, UKM FST Postgraduate Colloquium . 2014

5. Crystal structures and Hirshfeld surface analysis of trans-bis(thiocyanato-κN)bis{246-trimethyl-N-(pyridin-2-yl)methylideneaniline-κ2NN′}manganese(II) and trans-bis(thiocyanato-κN)bis{246-trimethyl-N-(pyridin-2-yl)methylideneaniline-κ2NN′}nickel(II)) [O] . Siripak Jittirattanakun, Chatphorn Theppitak, Nanthawat Wannarit, 2020

6. CCDC 1061305: Experimental Crystal Structure Determination : Dichloro-(P,P-di-t-butyl-N-(6-(1-methyl-1H-benzimidazol-2-yl)pyridin-2-yl)phosphinous amide)-cobalt dichloro-(P,P-di-t-butyl-N-(6-(1-methyl-1H-benzimidazol-2-yl)pyridin-2-yl)phosphinic amide)-(dimethylformamide)-cobalt dimethylformamide solvate [O] . Liu, Wen, Pan, Weijing, Wang, Peng, 2015

1. 3D-QSAR Studies on 4-(1,2,4Triazolo1,5-α pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole Analogues as Potent Inhibitors of Transforming Growth Factor-β Type Ⅰ Receptor Kinase [J] . SUN Li-Qian ,MENG Li-Qiang ,YAN Chao-Qun . 结构化学 . 2018,第004期

2. Syntheses and Structures of Two Metal-organic Frameworks Constructed from Zn/Ni and 3-Formyl-4-(pyridin-4-yl) Benzoic Acid Ligand [J] . ANEES ABBAS ,ZHANG Jie ,LI Zi-Jian . 结构化学 . 2018,第002期

3. 粉末活性炭对水中嗅味物质2-甲氧基-3-异丙基吡嗪和2-甲氧基-3-异丙基吡嗪的吸附特性研究 [C] . 安娜 ,高乃云 ,谢茴茴 . 中国土木工程学会水工业分会全国给水深度处理研究会2013年年会 . 2013

4. 盐酸羟哌吡酮(Yl-0919)抗抑郁作用及其神经可塑性机制研究 [A] . 胡晓旭 . 2014